RecruitingPhase 1NCT06455280
A Study of SIPLIZUMAB in AILD and LT Patients
Studying Autoimmune hepatitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Elizabeth C. Verna
- Principal Investigator
- Elizabeth Verna, MDColumbia University Irving Medical Center/ New York Presbyterian Hospital
- Intervention
- Siplizumab(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2028
Study locations (1)
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States
Collaborators
ITB-Med LLC
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06455280 on ClinicalTrials.govOther trials for Autoimmune hepatitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07378202Machine Learning for Prediction of Therapy Response in Autoimmune HepatitisHannover Medical School
- RECRUITINGPHASE2NCT06381453Belimumab in Autoimmune HepatitisUniversity Health Network, Toronto
- ENROLLING BY INVITATIONNCT06061341TruGraf Liver Gene Expression Serial TestWashington University School of Medicine
- RECRUITINGNCT06519162Liver-gut Axis Study Through Identification of Liver Disease-specific MicrobiomeChungnam National University Hospital
- RECRUITINGNANCT06250309Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis PatientsIndiana University
- RECRUITINGNCT05810480PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin GHannover Medical School
- RECRUITINGNCT06078098Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample StorageUniversity of Milano Bicocca
- RECRUITINGNCT05785793Autoimmune Hepatitis Cohort in ChinaShanghai Jiao Tong University School of Medicine